Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Madison WI, Milwaukee WI, Park Ridge IL, Maywood IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Madison WI, Milwaukee WI, DeKalb IL, Grayslake IL,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase 3, Recruiting
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Madison WI, Philadelphia PA, Houston TX, Tampa FL
Sponsor: Verismo Therapeutics
Sex: All
Age: 18+
Code: NCT05568680
Phase 1, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Get alerts for new trials in your area by subscribing now
A Prospective Sub-Study of the Global Hypophosphatasia Registry
for
Hypophosphatasia
Location: Madison WI, Chicago IL, Kansas City MO, Columbus OH,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT05234567
Recruiting
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
for
Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Location: Madison WI, Indianapolis IN, St Louis MO, Cincinnati OH,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 40 - 55
Code: NCT07636811
Phase 2, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Madison WI, Elmhurst IL, Chicago IL, Minneapolis MN,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for
Endometrial Cancer, Gastric Cancer,
Location: Madison WI, Grand Rapids MI, Cincinnati OH, Columbus OH,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05489211
Phase 2, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Madison WI, Arlington Heights IL, Evanston IL,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Madison WI, Milwaukee WI, Maywood IL, Chicago IL,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Madison WI, Chicago IL, Columbus OH, Nashville TN,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06501196
Phase 1, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Madison WI, Chicago IL, Rochester MN, Grand Rapids MI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase 3, Recruiting
CAR-T Long Term Follow Up (LTFU) Study
for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Madison WI, Chicago IL, Ann Arbor MI, Detroit MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT02445222
Phase 3, Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies